NCT06213610View on ClinicalTrials.gov

Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

March 6, 2024

Study Completion Date

June 1, 2024

Conditions
Bioequivalence
Interventions
DRUG

Perindopril tablet

Perindopril is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 8 mg of perindopril tert-butylamine.

DRUG

Prestarium® A tablet

Prestarium® A is manufactured by Les Laboratoires Servier Industrie, France. Each tablet contains 10 mg of perindopril arginine.

Trial Locations (1)

Unknown

RECRUITING

Ligand Research LLC, Moscow

All Listed Sponsors
lead

Pharmtechnology LLC

INDUSTRY